83257-0001 OGIVRI - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

83257-0001

Brand Name:

OGIVRI

Generic Name:

Trastuzumab-dkst

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/7.4mL

Packages:

Code: 83257-0001-11

Description: 1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL

Effective Date: Oct. 1, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use